Literature DB >> 23806777

Increased phosphorylation of mTOR is involved in remote ischemic preconditioning of hippocampus in mice.

Fatemeh Zare Mehrjerdi1, Nahid Aboutaleb, Rouhollah Habibey, Marjan Ajami, Mansoureh Soleimani, Maedeh Arabian, Somayeh Niknazar, Sayed Hossein Davoodi, Hamidreza Pazoki-Toroudi.   

Abstract

Different signaling pathways are involved in tissue protection against ischemia reperfusion (IR) injury, among them mammalian target of rapamycin (mTOR) and related pathways have been examined in many recent studies. Present study evaluated the role of mTOR in remote ischemic preconditioning (RIPC) of hippocampus. Renal ischemia was induced (3 cycles of 5min occlusion and 5min reperfusion of unilateral renal artery) 24h before global brain ischemia (20min bilateral common carotid artery occlusion). Saline or rapamycin (mTOR inhibitor; 5mg/kg, i.p.) was injected 30min before RIPC. mTOR and phosphorylated mTOR (p-mTOR) expression, superoxide dismutase (SOD) activity and retention trial of passive avoidance test were determined 24h after global ischemia. Apoptosis and neuronal cell density were assessed 72h after hippocampal ischemia. RIPC decreased apoptosis (p<0.05 vs. IR), improved memory (p<0.05 vs. IR), and augmented p-mTOR expression and SOD activity after hippocampal ischemia (p<0.05 vs. IR). Rapamycin abolished all protective effects of RIPC (p<0.05 vs. RIPC+IR) suggesting a role for mTOR in RIPC induced hippocampal protection.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP sensitive potassium channels; Apoptosis; CCA; Common carotid artery; IR; Ischemia reperfusion; KATP; MAPK; Mammalian target of rapamycin; Memory; Mitochondrial ATP sensitive potassium channels; Mitogen activated protein kinases; PAT; Passive avoidance test; RIPC; ROS; Rapa; Rapamycin; Reactive Oxygen Species; Remote ischemia preconditioning; Remote ischemic preconditioning; SOD; Superoxide dismutase; mKATP; mTOR

Mesh:

Substances:

Year:  2013        PMID: 23806777     DOI: 10.1016/j.brainres.2013.06.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

Review 1.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 2.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

Review 3.  Cutting through the complexities of mTOR for the treatment of stroke.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014-05       Impact factor: 1.990

4.  Two episodes of remote ischemia preconditioning improve motor and sensory function of hind limbs after spinal cord ischemic injury.

Authors:  Salah Omar Bashir; Mohamed Darwesh Morsy; Dalia Fathy El Agamy
Journal:  J Spinal Cord Med       Date:  2019-04-15       Impact factor: 1.985

5.  The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.

Authors:  Lin Li
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

Review 6.  Rodent Gymnastics: Neurobehavioral Assays in Ischemic Stroke.

Authors:  Sreekala S Nampoothiri; Tanvi Potluri; Harshith Subramanian; Rajanikant G Krishnamurthy
Journal:  Mol Neurobiol       Date:  2016-10-17       Impact factor: 5.590

7.  The Protective Effect of Remote Renal Preconditioning Against Hippocampal Ischemia Reperfusion Injury: Role of KATP Channels.

Authors:  Fatemeh Zare Mehrjerdi; Nahid Aboutaleb; Hamidreza Pazoki-Toroudi; Mansoureh Soleimani; Marjan Ajami; Mehdi Khaksari; Fatemeh Safari; Rouhollah Habibey
Journal:  J Mol Neurosci       Date:  2015-08-09       Impact factor: 3.444

8.  The role of erythropoietin in remote renal preconditioning on hippocampus ischemia/reperfusion injury.

Authors:  Mehdi Khaksari; Fatemeh Zare Mehrjerdi; Mohammad Ebrahim Rezvani; Fatemeh Safari; Aghdas Mirgalili; Somayeh Niknazar
Journal:  J Physiol Sci       Date:  2016-04-20       Impact factor: 2.781

Review 9.  WISP1: Clinical insights for a proliferative and restorative member of the CCN family.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

Review 10.  Taking aim at Alzheimer's disease through the mammalian target of rapamycin.

Authors:  Kenneth Maiese
Journal:  Ann Med       Date:  2014-08-08       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.